[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 1906 Introduced in Senate (IS)]
114th CONGRESS
1st Session
S. 1906
To clarify the exclusion of orphan drug sales from the calculation of
the annual fee on branded prescription pharmaceutical manufacturers and
importers, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
July 30, 2015
Mr. Menendez (for himself and Mr. Crapo) introduced the following bill;
which was read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To clarify the exclusion of orphan drug sales from the calculation of
the annual fee on branded prescription pharmaceutical manufacturers and
importers, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Orphan Drug Fairness Act''.
SEC. 2. EXCLUSION OF ORPHAN DRUG SALES.
(a) In General.--Paragraph (3) of section 9008(e) of the Patient
Protection and Affordable Care Act (26 U.S.C. 4001 note prec.; Public
Law 111-148) is amended to read as follows:
``(3) Exclusion of orphan drug sales.--The term `branded
prescription drug sales' shall not include sales of any drug or
biological product with respect to which a credit was allowable
for any taxable year under section 45C of the Internal Revenue
Code of 1986, regardless of whether such credit was claimed and
received. The preceding sentence shall not apply with respect
to any such drug or biological product after the date on which
such drug or biological product is approved by the Food and
Drug Administration for marketing for any indication other than
the treatment of the rare disease or condition with respect to
which such credit was allowable.''.
(b) Effective Date.--The amendment made by subsection (a) shall
take effect as if included in section 9008 of the Patient Protection
and Affordable Care Act (26 U.S.C. 4001 note prec.; Public Law 111-
148).
<all>